Corrigendum to “Favipiravir vs. Deferiprone: tautomeric, photophysical, in vitro biological studies, and binding interactions with SARS-Cov-2-MPro/ACE2” [Curr. Res. Biotechnol. 7 (2024) 100176]

Corrigendum to “Favipiravir vs. Deferiprone: tautomeric, photophysical, in vitro biological studies, and binding interactions with SARS-Cov-2-MPro/ACE2” [Curr. Res. Biotechnol. 7 (2024) 100176]

Saved in:

Bibliographic Details
Main Authors:	Nikolay T. Tzvetkov, Martina I. Peeva, Maya G. Georgieva, Vera Deneva, Aneliya A. Balacheva, Ivan P. Bogdanov, Maria Ponticelli, Luigi Milella, Kiril Kirilov, Maima Matin, Hans-Georg Stammler, Atanas G. Atanasov, Liudmil Antonov
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Current Research in Biotechnology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590262825000152
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tautomerism and switching in 7-hydroxy-8-(azophenyl)quinoline and similar compounds
by: Lidia Zaharieva, et al.
Published: (2025-07-01)

Neurotensin(8-13) analogs targeting NTS1 and NTS2 receptors: A comparative in vitro and molecular modeling study
by: Kiril Kirilov, et al.
Published: (2025-01-01)

Corrigendum to “A review: Anti-obesity drug discovery from natural plant metabolites and endogenous peptides” [Curr. Res. Biotechnol. 8 (2024) 100259]
by: Xiaomu Zhu, et al.
Published: (2025-01-01)

Corrigendum to “Synthesis and analgesic activity of new analogs of FELL tetrapeptide containing D-Phe in the first position” [Curr. Res. Biotechnol. 8 (2024) 100249]
by: Boryana Borisova, et al.
Published: (2025-01-01)

Corrigendum to “Postbiotics, a natural feed additive for growth performance, gut microbiota and quality of poultry products” [Curr. Res. Biotechnol. 8 (2024) 100247]
by: Jakub Urban, et al.
Published: (2025-01-01)

Corrigendum to “Cost-effective production process of scFv antibody fragments against Shiga toxin 2 via recombinant E. coli” [Curr. Res. Biotechnol. 10 (2025) 100310]
by: Marcela Guimarães, et al.
Published: (2025-01-01)

8-(Pyridin-2-yl)quinolin-7-ol and Beyond: Theoretical Design of Tautomeric Molecular Switches with Pyridine as a Proton Crane Unit
by: Lidia Zaharieva, et al.
Published: (2024-12-01)

The Prototropic Tautomerism of Heteroaromatic Compounds
by: A.R. Katritzky
Published: (1970-04-01)

Comparative Efficacy of Deferiprone, Deferoxamine and Combination of Deferiprone and Deferoxamine on Serum Ferritin Value in Beta-Thalassemia Patients
by: Nargesbeygom Mirbehbahani, et al.
Published: (2015-01-01)

Über Keto-Enol-Tautomere als Polymerisationsinitiatoren
by: H. Hopff, et al.
Published: (1965-03-01)

Deferiprone protects against photoreceptor degeneration by inhibiting parthanatos
by: Beatriz Villarejo-Zori, et al.
Published: (2025-05-01)

Thione-thiol tautomerism of thiourea ligands on silica surface
by: O. V. Smirnova, et al.
Published: (2015-05-01)

Theoretical Investigation of Solvation Effects on the Tautomerism of Maleic Hydrazide
by: Meisam Shabanian, et al.
Published: (2012-01-01)

Development of Nanocomposite Microspheres for Nasal Administration of Deferiprone in Neurodegenerative Disorders
by: Radka Boyuklieva, et al.
Published: (2024-11-01)

The effect of favipiravir on fracture healing
by: Mehmet Ali Sabır, et al.
Published: (2024-05-01)

THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA
by: George J Kontoghiorghes, et al.
Published: (2020-01-01)

Inhibitory efficacy and structural insights of Bofutrelvir against SARS-CoV-2 Mpro mutants and MERS-CoV Mpro
by: Weiwei Wang, et al.
Published: (2025-03-01)

Exploring Possible Drug-Resistant Variants of SARS-CoV‑2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61
by: Jessica R. Kenneson, et al.
Published: (2025-01-01)

Pharmacokinetic Interaction of Favipiravir with Citalopram and Pioglitazone
by: Zeliha Keskin Alkaç, et al.
Published: (2022-12-01)

Chelation Therapy with Oral Solution of Deferiprone in Transfusional Iron-Overloaded Children with Hemoglobinopathies
by: Alexandros Makis, et al.
Published: (2013-01-01)

Withdrawal notice to “Corrigendum to: 'Cryo-EM reveals architectural diversity in active Rotavirus particles'. Comput. Struct. Biotechnol. J. 2019 Jul 31; 17:1178-1183” [Comput. Struct. Biotechnol. J. 23 (2024) 3702]
by: Mary Hauser, et al.
Published: (2025-01-01)

EUROPEAN BADGER (MELES MELES LINNAEUS, 1758) PREFERENCES TO THE TERRAIN EXPOSURE FOR DIGGING DENS IN SOUTHEASTERN BULGARIA
by: S. Peeva, et al.
Published: (2021-06-01)

Quantitative Analysis of Favipiravir by HPLC: Development and Validation
by: Moammal Qurt, et al.
Published: (2023-01-01)

Corrigendum to “Lipid droplets dependent or independent cytoprotective activities of unsaturated fatty acids, Lorenzo’s oil and sulfo-N-succinimidyl oleate on 7-ketocholesterol-induced oxidative stress, organelle dysfunction and cell death on 158N and ARPE-19 cells: Cell targets and benefits of sulfo-N-succinimidyl oleate” [Curr. Res. Biotechnol. 7 (2024) 100195]
by: Thomas Nury, et al.
Published: (2025-01-01)

Pharmacogenetic Markers of Favipiravir Safety in COVID-19 Treatment
by: I. I. Temirbulatov, et al.
Published: (2023-10-01)

A Retrospective Analysis of Treatment of Covid-19 with Favipiravir
by: Aigul Utegenova, et al.
Published: (2022-06-01)

Amoxicillin and Favipiravir Bio-Degradation by Aspergillus Flavus Fungus
by: Rana Hadi Hameed Al-Shammari, et al.
Published: (2024-10-01)

Ensuring safe operating conditions for power transformers under thermal effects of short-circuit curre
by: A. V. Kostyukov, et al.
Published: (2018-06-01)

N‐methylation of histidine to tune tautomeric preferences in histidine‐heme coordination and enzyme‐mimetic catalysis
by: Ruikai Du, et al.
Published: (2024-09-01)

Influence of pyridinic nitrogen on tautomeric shifts and charge transport in single molecule keto enol equilibria
by: G. R. Berdiyorov
Published: (2025-01-01)

An Investigation of Nirmatrelvir (Paxlovid) Resistance in SARS-CoV‑2 Mpro
by: Rasha M. Yaghi, et al.
Published: (2024-10-01)

Prevention of adhesions post-abdominal surgery: Assessing the safety and efficacy of Chitogel with Deferiprone in a rat model.
by: Rajan Sundaresan Vediappan, et al.
Published: (2021-01-01)

Solubility data of deferiprone in propylene glycol and 1-propanol mixtures at 293.2–323.2 K
by: Homa Rezaei, et al.
Published: (2025-03-01)

Theoretical study of the structures of Schiff base compounds and thermodynamic study of the tautomerism reactions by ab initio calculations
by: Ali Hossein Kianfar, et al.
Published: (2017-12-01)

Supramolecular drug-laden hydrogel based on structural tautomerization enhances drug delivery for rheumatoid arthritis treatment
by: Hao Li, et al.
Published: (2025-11-01)

Solvent polarity effect on photophysical properties of some aromatic azo dyes with focus on tautomeric and toxicity competition
by: Bita Taheri, et al.
Published: (2025-05-01)

Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-09-01)

Magnetic orange leaf biochar for favipiravir removal from wastewater
by: Seyed Ehsan Azizzadeh, et al.
Published: (2025-07-01)

EFFECTIVENESS AND SAFETY OF FAVIPIRAVIR INFUSION IN PATIENTS HOSPITALIZED WITH COVID-19
by: L. A. Balykova, et al.
Published: (2022-03-01)

Unraveling Biodegradation Mechanisms of Favipiravir by the Partial Nitritation Granular Sludge
by: Liang Xinyu, et al.
Published: (2025-01-01)